This might occur in patients diagnosed with COVID-19 owing to the genome sequence similarity (Zhou et al., 2020) and it has been proven that approximately 2–11% patients had liver comorbidities and 14–53% possess abnormal alanine aminotransferase (ALT) and aspartate aminotransferase (AST) level which occurred more in severe cases of COVID-19 (Zhang et al., 2020). The gene discussed is GPT; the disease is COVID-19.